PP-060 Prevalence and antimicrobial susceptibility of
Campylobacter spp. isolated from beef and raw chicken in Tehran, Iran 
Toshiba General Hospital
Background: It is assumed that patients with CHB with high DNA exhibit increased liver damage and treatment guidelines emphasize on reducing viral load. These observations are from developed countries, but little is known about >80% HBsAg carriers living in developing nations. In this study, we addressed this issue. Methods: 402 Bangladeshi CHB patients were enrolled and tested for HBV serologic markers and ALT. All underwent liver biopsy. HBV genotyping was done in 45. Result: High HBV DNA (>100,000 copies/ml) was detected in 64.4%. 43.5% were HBeAg +ve and 56.5% HBeAg -ve. HAI-NI ≥3 was in 62.9% HBeAg +ve and 49.8% HBeAg -ve respectively. In high HBV DNA, 59.8% had higher HAI-NI, opposed to 45.5% with low DNA. Much more with low DNA had considerable hepatic fibrosis compared to high DNA. However difference in HAI-F was not significant. Genotyping was done in 45. Genotype C (38%) and D (49%) were predominant. Comparison between HBV genotype, DNA load and liver damage could not be done because genotyping was done in only 45. Conclusion: Correlation could not be established between viral load and liver damage in CHB in Bangladesh. Further study is needed to identify other factors influencing liver damage in CHB in developing nations. Our study may suggest the research direction for management of these cases. Results: MTT method confirmend that the nontoxic concentrations of MP and FK506 were 0-500uk/ml. After the treatment of MP at the concentration of 0, 5, 10, 20, 50, 100, 250 and 500 μg/L, in comparison to the control group. MP was able to
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